Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/ p-Tyr216-GSK-3β/β-catenin axis
Authors:
- 1 February 2017
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 38 (2) , 1035-1042
Abstract
Cervical cancer is the second most common gynecological malignancy. The mechanisms of the genesis and progression of cervical cancer are complicated and not thoroughly understood. DEK is reported as an oncogene in various cancers, such as acute myeloid leukemia, bladder cancer, breast cancer and hepatocellular cancer. However, its role in cervical cancer has not been well studied. In our study, we confirmed the DEK protein as an oncoprotein in cervical cancer tissues which is correlated to cervical cancer FIGO staging and tumor type. Moreover, in vitro loss of DEK inhibited cervical cancer cell proliferation, migration and invasion. We proved that silencing DEK downregulated Wnt/β-catenin and MMP-9, and silencing DEK increased GSK-3β activity via regulating its phosphorylation instead of translation. Silencing DEK reduced p-Ser9-GSK-3β and increased p-Tyr216-GSK-3β, which resulted in β-catenin degradation. Finally, the xenograft model in nude mice proved that silencing DEK impaired cervical cancer cell tumorigenicity. This research unveiled the function of DEK in tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis in cervical cancer and gave insights into DEK-targeting therapy for patients suffering from cervical cancer.Keywords
This publication has 38 references indexed in Scilit:
- Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania MedicaidObstetrics & Gynecology, 2017
- Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin StudyTwin Research and Human Genetics, 2016
- Cervical Cancer ScreeningObstetrics & Gynecology, 2016
- Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinomaOncology Reports, 2015
- The DEK oncoprotein and its emerging roles in gene regulationLeukemia, 2015
- The DEK oncoprotein is upregulated by multiple leukemia-associated fusion genesBlood Cells, Molecules, and Diseases, 2015
- Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinomaMolecular Medicine Reports, 2014
- The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stressOncogene, 2014
- DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation ProgramThe American Journal of Pathology, 2009
- Overview: Genes that predispose to cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991